(Q44438563)

3 December 2017

title

Treatment of intraocular retinoblastoma with vincristine and carboplatin (English)

1 reference

3 December 2017

Treatment of Intraocular Retinoblastoma With Vincristine and Carboplatin (English)

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

1 January 2024

1 reference

intraocular retinoblastoma

1 reference

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

1 January 2024

2

Matthew W Wilson

1 reference

3 December 2017

author name string

Carlos Rodriguez-Galindo

1

1 reference

3 December 2017

Nirali Shah

6

1 reference

3 December 2017

Alvida Cain

7

1 reference

3 December 2017

James Langston

8

1 reference

3 December 2017

Mindy Lipson

9

1 reference

3 December 2017

Barrett G. Haik

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743157

1 January 2024

Thomas E. Merchant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743157

1 January 2024

Catherine A. Billups

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743157

1 January 2024

Larry E. Kun

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743157

1 January 2024

Charles B. Pratt

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743157

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

15 May 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743157

full work available at URL

1 January 2024

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.09.103

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Journal of Clinical Oncology

1 January 2024

published in

1 reference

3 December 2017

volume

21

1 reference

3 December 2017

issue

10

1 reference

3 December 2017

page(s)

2019-2025

1 reference

Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type.

3 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

The development of young children with retinoblastoma

1 January 2024

2

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

1 January 2024

5

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Successful treatment of metastatic retinoblastoma

1 January 2024

6

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Mortality from second tumors among long-term survivors of retinoblastoma

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy

1 January 2024

10

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

The hourglass facial deformity as a consequence of orbital irradiation for bilateral retinoblastoma

1 January 2024

11

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Orbital development in long-term survivors of retinoblastoma

1 January 2024

12

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk

1 January 2024

13

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastoma

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

The pharmacokinetics of high-dose carboplatin in pediatric patients with cancer

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Optimal two-stage designs for phase II clinical trials

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Cytogenetic analysis of retinoblastoma: evidence for multifocal origin and in vivo gene amplification

1 January 2024

18

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.

1 January 2024

20

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Role of chemotherapy alone or in combination with hyperthermia in the primary treatment of intraocular retinoblastoma: preliminary results

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

First-line chemotherapy with local treatment can prevent external-beam irradiation and enucleation in low-stage intraocular retinoblastoma

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy

1 January 2024

25

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma

1 January 2024

26

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

1 January 2024

27

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Chemotherapy plus local treatment in the management of intraocular retinoblastoma

1 January 2024

30

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Chemothermotherapy in the management of retinoblastoma.

1 January 2024

31

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Penetration of Chemotherapy Into Vitreous Is Increased by Cryotherapy and Cyclosporine in Rabbits

1 January 2024

32

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma

1 January 2024

33

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

External beam radiotherapy in retinoblastoma: tumor control and comparison of 2 techniques

1 January 2024

34

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

External beam radiotherapy for retinoblastoma: I. Whole eye technique

1 January 2024

35

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

External beam radiotherapy for retinoblastoma: II. Lens sparing technique

1 January 2024

36

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma

1 January 2024

37

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma

1 January 2024

38

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Retinoblastoma treated with primary chemotherapy alone: the significance of tumour size, location, and age

1 January 2024

39

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Clinicopathologic reports, case reports, and small case series: rapidly progressive T-cell lymphoma of the conjunctiva

1 January 2024

40

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Intraocular concentrations of chemotherapeutic agents after systemic or local administration

1 January 2024

41

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma.

1 January 2024

42

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule

1 January 2024

43

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

A phase I/II study of subconjunctival carboplatin for intraocular retinoblastoma

1 January 2024

44

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk?

1 January 2024

45

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Ocular preservation after 36 Gy external beam radiation therapy for retinoblastoma

1 January 2024

46

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).

1 January 2024

47

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma

1 January 2024

48

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia

1 January 2024

49

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia

1 January 2024

50

1 reference

https://api.crossref.org/works/10.1200/JCO.2003.09.103

1 January 2024

Identifiers

1 reference

release_c5gxemfqnrazdpflnmsd44knf4

3 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c5gxemfqnrazdpflnmsd44knf4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference